Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep429 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Patient with pancreatic diabetes and insulin pump

Pappa Dimitra , Barmpa Eleftheria , Linaras Maistros , Tsakos Panagiotis , Zikos Nikolaos , Bargiota Alexandra

Introduction: Pancreatic diabetes is a special category of diabetes due to diseases of the exocrine pancreas, characterized by both insulin and glucagon deficiency and clinically could be very challenging to control. We present a case of a woman with pancreatic diabetes treated with sensor augmented pump therapy after undergoing total pancreatectomy for a nonfunctional pancreatic neuroendocrine tumor (NET).Presentation: A sixty-one years old woman underw...

ea0050p272 | Neuroendocrinology and Pituitary | SFEBES2017

The severity of obstructive sleep apnoea does not influence ambient IGF-I levels

Lynch Julie , Kyriakakis Nikolaos , Elliott Mark , Ghosh Dipansu , Nix Mitchell , Watts Sue , Murray Robert D

Introduction: Obstructive sleep apnoea (OSA) is reported to have effects on a number of hormone systems including glycaemic control, catecholamines, and the HPA axis. In this study we aimed to determine the impact of OSA on IGF-I levels.Patients & Methods: This is a prospective cohort study performed at Leeds Teaching Hospitals. Patients were recruited from the Sleep Apnoea Clinic between November 2014 and May 2...

ea0050p292 | Neuroendocrinology and Pituitary | SFEBES2017

The burden of arthropathy in acromegaly: results from an observational study

Kyriakakis Nikolaos , Lynch Julie , Orme Steve M , Gilbey Stephen G , Conaghan Philip , Murray Robert D

Introduction: Patients with acromegaly are often left with long-term sequelae, among which arthropathy is the most common. Studies have shown impaired quality of life (QoL) in patients with acromegaly, even after long-term remission. Arthropathy is a negative predictive factor of QoL, due to its impact on physical symptoms and functioning.Patients/Methods: To characterise further the extent of the acromegalic arthop...

ea0050p272 | Neuroendocrinology and Pituitary | SFEBES2017

The severity of obstructive sleep apnoea does not influence ambient IGF-I levels

Lynch Julie , Kyriakakis Nikolaos , Elliott Mark , Ghosh Dipansu , Nix Mitchell , Watts Sue , Murray Robert D

Introduction: Obstructive sleep apnoea (OSA) is reported to have effects on a number of hormone systems including glycaemic control, catecholamines, and the HPA axis. In this study we aimed to determine the impact of OSA on IGF-I levels.Patients & Methods: This is a prospective cohort study performed at Leeds Teaching Hospitals. Patients were recruited from the Sleep Apnoea Clinic between November 2014 and May 2...

ea0050p292 | Neuroendocrinology and Pituitary | SFEBES2017

The burden of arthropathy in acromegaly: results from an observational study

Kyriakakis Nikolaos , Lynch Julie , Orme Steve M , Gilbey Stephen G , Conaghan Philip , Murray Robert D

Introduction: Patients with acromegaly are often left with long-term sequelae, among which arthropathy is the most common. Studies have shown impaired quality of life (QoL) in patients with acromegaly, even after long-term remission. Arthropathy is a negative predictive factor of QoL, due to its impact on physical symptoms and functioning.Patients/Methods: To characterise further the extent of the acromegalic arthop...

ea0084op-06-30 | Oral Session 6: Hypothyroidism | ETA2022

Levothyroxine replacement therapy overuse and factors guiding successful treatment discontinuation: short and long-term observation data of a large cohort

Livadas Sarantis , Androulakis Ioannis , Angelopoulos Nikolaos , Anagnostis Panagiotis , Paparodis Rodis , Boniakos Anastasios , Askitis Dimitrios , Duntas Leonidas

Background: Levothyroxine (LT4Rx) is one of the most prescribed drugs worldwide the vast majority of patients receive long-term treatment. However, in a recent study of 291 subjects, it was found that 60% were euthyroid 2 months after LT4-Rx discontinuation1.Aim of the study: A prospective clinical cohort follow-up study was carried out. In 688 subjects (82% females) aged 48.01±15.96 (range 17-84years) with 8.59±6.98 years on LT4Rx witho...

ea0090oc4.6 | Oral Communications 4: Reproductive and Developmental Endocrinology | ECE2023

The severity of hot flashes is associated with the risk for incident metabolic syndrome and new-onset hypertension after the menopause

Armeni Elena , Augoulea Areti , Efstathiou Andreas , Chatzivasileiou Panagiota , Kaparos George , Vlahos Nikolaos , Eleftheriades Makarios , Lambrinoudaki Irene

Introduction: A growing body of evidence supports the possible association between the severity of climacteric symptoms and long-term cardiometabolic risk. We aimed to assess the possible link between the severity of hot flashes and the risk for cardiometabolic manifestations after the menopausal transition.Methods: This cohort study was conducted in the Menopause Clinic, National and Kapodistrian University of Athens, Aretaieio Hospital, Athens, Greece....

ea0090p327 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The impact of Diabetes Mellitus in patients with Pulmonary Fibrotic Disease; disease progression and bronchoalveolar lavage evaluation

Tsakalomatis Panagiotis-Nikolaos , Vasarmidi Eirini , Tsitoura Eliza , Bibaki Eleni , Antoniou Katerina , Xekouki Paraskevi

Rationale/Objective: Diabetes Mellitus (DM) and Interstitial lung Disease (ILD) share common pathogenetic pathways involving inflammatory cells and in particular monocytes and macrophages. Diabetic patients are at higher risk of developing pulmonary fibrosis, whereas DM is a major comorbidity in ILD patients. In our study, we analyzed retrospectively patients with ILD and aimed to examine differential characteristics between patients with and without DM, including disease para...

ea0090p373 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Glycemic control in Type 1 Diabetes patients using multiple daily insulin injections (MDII) vs continuous subcutaneous insulin infusion (CSII)

Tsitsimpis Anastasios , Cherolidi Helen , Kalogeris Nikolaos , Spanou Loukia , Mouslech Tzant , Somali Maria , Georgiopoulos Georgios , Vryonidou Andromachi

Objective: Glycemic control of patients with type 1 diabetes is mainly based on insulin administration. The ongoing technological developments in continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) provide new treatment strategies, with better glycemic control. This study assessed the clinical impact of two treatment strategies in adults with type 1 diabetes (T1D): multiple daily insulin injections (MDII) vs continuous subcutaneous insulin i...

ea0090p508 | Thyroid | ECE2023

The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?

Angelopoulos Nikolaos , Paparodis Rodis , Androulakis Ioannis , Boniakos Anastasios , Karras Spyridon , Livadas Sarantis

Background: In the last decade, the combination of the widespread use of streptavidin-biotin technology and biotin–containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous hormone immunoassay results. However, there are no studies assessing the clinical and biochemical significance of that phenomenon, when treating patients with hypothyroidism. Therefore, a prospective study was designed to investigate the potential alteration...